RPTOR and chronic myelogenous leukemia, BCR-ABL1 positive: However, although our treatment of LT-CML stem cells with GlySar or cefadroxil increased phospho-AMPK, these agents did not promote Raptor-Ser792 phosphorylation (Supplementary Fig. 7).